Emerge Weight Loss vs RNK Health
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Emerge Weight Loss
Best for patients committed to tirzepatide as their drug of choiceStarting at $299/mo
RNK Health
Best for compounded GLP-1 buyers also interested in NAD+, peptide, or longevity add-ons in the same provider relationshipStarting at $197/mo
Side-by-Side Comparison
| Feature | Emerge Weight Loss | RNK Health |
|---|---|---|
| Overall Score | ✓7.6/10 | 7.3/10 |
| Starting Price | $299/mo | ✓$197/mo |
| Editorial Rating | ✓3.8 ★ /5 | 3.7 ★ /5 |
| Features | 4 features | ✓5 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Emerge Weight Loss
Pros
- ✓Tirzepatide-focused (largest effect-size compounded GLP-1)
- ✓Wide dose range available
- ✓Physician-supervised telemedicine model
Cons
- ✗No semaglutide option — limits flexibility if tirzepatide tolerability is poor
- ✗Less brand recognition than Henry Meds, Mochi, or SkinnyRx
RNK Health
Pros
- ✓Both injectable and oral compounded semaglutide formats — wider format optionality than most stub entries in the cluster
- ✓GLP-1 + longevity stack (NAD+, sermorelin, enclomiphene, DNA testing) lets one provider serve readers also interested in performance/longevity adjacencies
- ✓Pricing is publicly displayed — $297/mo tirzepatide, $197/mo injectable semaglutide, $198/mo oral semaglutide
Cons
- ✗States served not enumerated on the public landing page — needs direct confirmation before any state-page placement
- ✗Pharmacy partner not publicly named beyond a Springville, UT fulfillment reference
- ✗Compounded only on the GLP-1 side — no FDA-approved Wegovy/Zepbound brand-name option
Our Verdict
Emerge Weight Loss edges out RNK Health with a higher overall score of 7.6/10 and is particularly strong for patients committed to tirzepatide as their drug of choice. RNK Health remains a solid alternative, especially if you're looking for compounded GLP-1 buyers also interested in NAD+, peptide, or longevity add-ons in the same provider relationship.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.